On Wednesday, July 29, Hologic HOLX will report its last quarter's earnings. Here is Benzinga's preview of the company's release.
Earnings and Revenue
Analysts predict Hologic will report earnings of $0.37 per share on revenue of $607.71 million. Hologic reported a per-share profit of $0.630 when it published results during the same quarter last year. Sales in that period totaled $852.40 million. If the company were to report inline earnings when it publishes results Wednesday, quarterly profit would be down 41.27%. Sales would be down 18.69% on a year-over-year basis. Here's how the Hologic's reported EPS has stacked up against analyst estimates in the past:
| Quarter | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|
| EPS Estimate | 0.57 | 0.61 | 0.65 | 0.61 |
| EPS Actual | 0.57 | 0.61 | 0.65 | 0.63 |
| Revenue Estimate | 747.36 M | 839.82 M | 845.73 M | 835.74 M |
| Revenue Actual | 756.10 M | 850.50 M | 865.80 M | 852.40 M |
Stock Performance
For a full 12 months, the return has risen by 21.72%. Given that these returns are generally positive, long-term shareholders are probably relaxed going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.
Don't be surprised to see the stock move on comments made during its conference call. Hologic is scheduled to hold the call at 16:30:00 ET and can be accessed here: https://edge.media-server.com/mmc/p/e9eoejo2
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
